APA (7th ed.) Citation

Zhao, Z., Liu, Z., Zhang, K., Li, W., Zhang, L., Jiang, B., . . . Wang, X. (2025). Efficacy and safety of neoadjuvant therapy with tislelizumab plus axitinib for nonmetastatic renal cell carcinoma with inferior vena cava tumor thrombus: A retrospective study. Scientific Reports, 15(1), 1-8. https://doi.org/10.1038/s41598-025-86712-6

Chicago Style (17th ed.) Citation

Zhao, Zhongjie, Zhengsheng Liu, Kaiyan Zhang, Wei Li, Lijian Zhang, Bingliang Jiang, Bin Chen, Jinchun Xing, and Xuegang Wang. "Efficacy and Safety of Neoadjuvant Therapy with Tislelizumab Plus Axitinib for Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: A Retrospective Study." Scientific Reports 15, no. 1 (2025): 1-8. https://doi.org/10.1038/s41598-025-86712-6.

MLA (8th ed.) Citation

Zhao, Zhongjie, et al. "Efficacy and Safety of Neoadjuvant Therapy with Tislelizumab Plus Axitinib for Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: A Retrospective Study." Scientific Reports, vol. 15, no. 1, 2025, pp. 1-8, https://doi.org/10.1038/s41598-025-86712-6.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.